Decitabine
Dacogen, Decitabine (decitabine) is a small molecule pharmaceutical. Decitabine was first approved as Dacogen on 2006-05-02. It is used to treat myelodysplastic syndromes in the USA. It has been approved in Europe to treat myeloid leukemia. It is known to target cytidine deaminase.
| Trade Name | Dacogen |
|---|---|
| Common Name | Decitabine |
| Indication | myelodysplastic syndromes, myeloid leukemia |
| Drug Class | Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
